Company Overview and News
NEW YORK, Sept 12 — The benchmark S&P 500 and the Dow Jones Industrial Average were flat today, as gains in energy companies helped offset a slide in technology stocks, which weighed on the Nasdaq.
GILD XOM ASML GLPG
2018-09-12 marketwatch - 1
Micron Technology Inc. is leading memory-oriented tech stocks downward in Wednesday’s session, after another analyst expressed concern about supply and demand in the industry.
LRCX ASML WDC STX MU AMAT MS
U.S. stock index futures were flat early on Wednesday, held back by worries over the Sino-U.S. trade war, while Apple shares moved higher ahead of the expected launch of new iPhone models.
GILD XOM ASML GLPG
Investors are often concerned about the stock market in September, and the investment community is getting another look ahead at the lack of strength in the semiconductor capital equipment segment. Presenting at the Citi Global Technology Conference, KLA-Tencor Corp. (NASDAQ: KLAC) sent the whole industry lower on Thursday after tweaking its recovery expectations.
LRCX ASML KLIC ASML AMAT TRI KLAC
Shares of KLA-Tencor Corp. KLAC, -8.62% are down 9% in Thursday morning trading, after the company's chief financial officer gave a presentation at the Citi Global Technology Conference. He said that while the company still sees the September quarter as the "trough" for shipments, he delivered a "modestly weaker" view of his expectations for a rebound. Back when KLA-Tencor issued its outlook six weeks ago, the company "thought the December quarter would snap back pretty strongly," CFO Bren Higgins said Thursday, but he now thinks "it will be up a little less than what we thought," according to a FactSet transcript.
Researchers are divided on wafer fab equipment spending this year with Gartner projecting a 6% increase followed by cyclical correction in 2019 and 2020 after which the market is expected to return to growth. SEMI however sees 11.7% growth this year to $50.8 billion, with the front end growing stronger than the back-end.
LRCX ASML AMAT KLAC
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SPLK HAS GOOGL ASML OKTA ZS AMD MSFT NFLX GOOG
2018-07-19 reuters - 1
TOKYO, July 19 (Reuters) - Japan’s Nikkei share average gained on Thursday, hovering at a one-month high thanks to a softer yen as well as strong demand for energy, mining and chip equipment makers, though investors were wary of bidding up prices across-the-board given the recent rally.
ASML KIKOY KIKOF LN
Good afternoon ladies and gentlemen. Thank you for standing-by. Welcome to the ASML 2018 Second Quarter Financial Results Conference Call on July 18, 2018. Throughout today's introduction all participants will be in a listen-only mode. After ASML's introduction there will be an opportunity to ask your question.
The following slide deck was published by ASML Holding N.V. in conjunction with their 2018 Q2 earnings call.
(Reuters) - U.S. stock index futures hovered at five-month highs on Wednesday ahead of a slew of earnings, with a strong quarterly report from Morgan Stanley helping reaffirm a bullish outlook for the earnings season.
BRK.A ASML MS
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to AMS:ASML / ASML HOLDING on message board site Silicon Investor.
|ASML Holding NV||ASML Holding NV||ASML Holding NV|